Targeting of CD122 enhances antitumor immunity by altering the tumor immune environment
Villarreal, Daniel O, Allegrezza, Michael J, Smith, Melissa A, Chin, Diana, Luistro, Leopoldo L, Snyder, Linda A
Published in Oncotarget (12.12.2017)
Published in Oncotarget (12.12.2017)
Get full text
Journal Article
Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab
LUISTRO, LEOPOLDO L, ROSINSKI, JAMES A, BIAN, HONGJIN, BISHAYEE, SUBAL, RAMESHWAR, PRANELA, PONZIO, NICHOLAS M, RITLAND, STEVE R
Published in International journal of oncology (01.08.2012)
Published in International journal of oncology (01.08.2012)
Get full text
Journal Article
Abstract 5567: In vivo administration of the STING agonist, JNJ-67544412, leads to complete regression of established murine subcutaneous tumors
Smith, Melissa, Chin, Diana, Chan, Szeman, Mahady, Sally, Campion, Liam, Morgan, Caitlin, Patel, Shefali, Chu, Gerald, Hughes, Anna, Bignan, Gilles, Connolly, Pete, Emanuel, Stuart, Packman, Kathryn, Luistro, Leopoldo L.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab
LUISTRO, Leopoldo L, ROSINSKI, James A, HONGJIN BIAN, BISHAYEE, Subal, RAMESHWAR, Pranela, PONZIO, Nicholas M, RITLAND, Steve R
Published in International journal of oncology (2012)
Get full text
Published in International journal of oncology (2012)
Journal Article
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
Gaudet, Francois, Pillarisetti, Kodandaram, Majewski, Nathan, Luistro, III, Leopoldo L, Attar, Ricardo, Li, Yingzhe, Mendonca, Mark, Tornetta, Mark, Edavettal, Suzanne, Teplyakov, Alexey, Chin, Diana
Year of Publication 30.01.2024
Get full text
Year of Publication 30.01.2024
Patent
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
Gaudet, Francois, Pillarisetti, Kodandaram, Majewski, Nathan, Luistro, III, Leopoldo L, Attar, Ricardo, Li, Yingzhe, Mendonca, Mark, Tornetta, Mark, Edavettal, Suzanne, Teplyakov, Alexey, Chin, Diana
Year of Publication 27.06.2023
Get full text
Year of Publication 27.06.2023
Patent
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
Gaudet, Francois, Pillarisetti, Kodandaram, Majewski, Nathan, Luistro, III, Leopoldo L, Attar, Ricardo, Li, Yingzhe, Mendonca, Mark, Tornetta, Mark, Edavettal, Suzanne, Teplyakov, Alexey, Chin, Diana
Year of Publication 18.02.2020
Get full text
Year of Publication 18.02.2020
Patent
ANTI- GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF
Tornetta Mark, Teplyakov Alexey, Gaudet Francois, Li Yingzhe, Luistro, III Leopoldo L, Mendonca Mark, Majewski Nathan, Edavettal Suzanne, Pillarisetti Kodandaram, Chin Diana, Attar Ricardo
Year of Publication 08.02.2018
Get full text
Year of Publication 08.02.2018
Patent